{"slideshow_credits": null, "snippet": "In response Mylan&#8217;s move to the Netherlands, the Securities and Exchange Commission now requires shareholder votes for each governance change from such deals.", "abstract": "Steven Davidoff Solomon Deal Professor column notes SEC has been prompted to take stand on practice of corporate inversions because of corporate governance issues raised by deal that allowed drug maker Mylan to move its place of organization from Pennsylvania to Netherlands.", "section_name": "Business Day", "print_page": "4", "document_type": "article", "byline": {"person": [{"lastname": "SOLOMON", "rank": 1, "firstname": "Steven", "role": "reported", "organization": "", "middlename": "Davidoff"}], "original": "By STEVEN DAVIDOFF SOLOMON"}, "web_url": "http://www.nytimes.com/2015/11/04/business/dealbook/regulators-unbundle-some-attractions-of-mergers.html", "lead_paragraph": "In response Mylan&#8217;s move to the Netherlands, the Securities and Exchange Commission now requires shareholder votes for each governance change from such deals.", "headline": {"print_headline": "Regulators Unbundle Some Attractions of Mergers", "main": "Regulators Unbundle Some Attractions of Mergers", "content_kicker": "Deal Professor", "kicker": "Deal Professor"}, "_id": "5639615038f0d8786b6fe3ae", "word_count": "1016", "multimedia": [{"height": 126, "url": "images/2015/11/04/business/04DEALPROF/04DEALPROF-thumbWide-v2.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/11/04/business/04DEALPROF/04DEALPROF-thumbWide-v2.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 600, "url": "images/2015/11/04/business/04DEALPROF/04DEALPROF-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/04/business/04DEALPROF/04DEALPROF-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "600"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/11/04/business/04DEALPROF/04DEALPROF-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/04/business/04DEALPROF/04DEALPROF-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-11-04T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Mylan Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Medtronic Inc", "is_major": "N", "rank": "11"}, {"name": "organizations", "value": "Pfizer Inc", "is_major": "N", "rank": "12"}, {"name": "organizations", "value": "Teva Pharmaceutical Industries Ltd", "is_major": "N", "rank": "13"}, {"name": "subject", "value": "Corporate Taxes", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Securities and Exchange Commission", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Shareholder Rights and Activism", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "Perrigo Company", "is_major": "N", "rank": "7"}, {"name": "organizations", "value": "Allergan Inc", "is_major": "N", "rank": "8"}, {"name": "organizations", "value": "AstraZeneca PLC", "is_major": "N", "rank": "9"}, {"name": "organizations", "value": "Chiquita Brands International Inc", "is_major": "N", "rank": "10"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}